---
layout: post
title: "COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING"
date: 2026-02-05T13:00:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-2-0-million-registered-direct-offering-302680132.html
significance: 9.00
---

<p>REHOVOT, Israel, Feb. 5, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-2-0-million-registered-direct-offering-302680132.html)

**Published:** 2026-02-05 13:00:00 +0000

**Significance Score:** 9.00

[View original](https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-2-0-million-registered-direct-offering-302680132.html)
